176 related articles for article (PubMed ID: 37297025)
1. Resistance of Leukemia Cells to 5-Azacytidine: Different Responses to the Same Induction Protocol.
Šimoničová K; Janotka L; Kavcova H; Sulova Z; Messingerova L; Breier A
Cancers (Basel); 2023 Jun; 15(11):. PubMed ID: 37297025
[TBL] [Abstract][Full Text] [Related]
2. Changes in Apoptotic Pathways in MOLM-13 Cell Lines after Induction of Resistance to Hypomethylating Agents.
Janotka Ľ; Messingerová L; Šimoničová K; Kavcová H; Elefantová K; Sulová Z; Breier A
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669837
[TBL] [Abstract][Full Text] [Related]
3. Adult T-cell leukemia-lymphoma acquires resistance to DNA demethylating agents through dysregulation of enzymes involved in pyrimidine metabolism.
Yoshida-Sakai N; Watanabe T; Yamamoto Y; Ureshino H; Kamachi K; Kurahashi Y; Fukuda-Kurahashi Y; Kimura S
Int J Cancer; 2022 Apr; 150(7):1184-1197. PubMed ID: 34913485
[TBL] [Abstract][Full Text] [Related]
4. Different mechanisms of drug resistance to hypomethylating agents in the treatment of myelodysplastic syndromes and acute myeloid leukemia.
Šimoničová K; Janotka Ľ; Kavcová H; Sulová Z; Breier A; Messingerova L
Drug Resist Updat; 2022 Mar; 61():100805. PubMed ID: 35227933
[TBL] [Abstract][Full Text] [Related]
5. Effect of uridine on response of 5-azacytidine-resistant human leukemic cells to inhibitors of de novo pyrimidine synthesis.
Grant S; Bhalla K; Gleyzer M
Cancer Res; 1984 Dec; 44(12 Pt 1):5505-10. PubMed ID: 6208998
[TBL] [Abstract][Full Text] [Related]
6. Teriflunomide restores 5-azacytidine sensitivity via activation of pyrimidine salvage in 5-azacytidine-resistant leukemia cells.
Imanishi S; Takahashi R; Katagiri S; Kobayashi C; Umezu T; Ohyashiki K; Ohyashiki JH
Oncotarget; 2017 Sep; 8(41):69906-69915. PubMed ID: 29050250
[TBL] [Abstract][Full Text] [Related]
7. Deubiquitinase USP28 inhibits ubiquitin ligase KLHL2-mediated uridine-cytidine kinase 1 degradation and confers sensitivity to 5'-azacytidine-resistant human leukemia cells.
Zhang H; Huang H; Feng X; Song H; Zhang Z; Shen A; Qiu X
Theranostics; 2020; 10(3):1046-1059. PubMed ID: 31938050
[TBL] [Abstract][Full Text] [Related]
8. Reprogramming of pyrimidine nucleotide metabolism supports vigorous cell proliferation of normal and malignant T cells.
Watanabe T; Yamamoto Y; Kurahashi Y; Kawasoe K; Kidoguchi K; Ureshino H; Kamachi K; Yoshida-Sakai N; Fukuda-Kurahashi Y; Nakamura H; Okada S; Sueoka E; Kimura S
Blood Adv; 2024 Mar; 8(6):1345-1358. PubMed ID: 38190613
[TBL] [Abstract][Full Text] [Related]
9. Cellular differentiation, cytidine analogs and DNA methylation.
Jones PA; Taylor SM
Cell; 1980 May; 20(1):85-93. PubMed ID: 6156004
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of resistance to 5-aza-2'-deoxycytidine in human cancer cell lines.
Qin T; Jelinek J; Si J; Shu J; Issa JP
Blood; 2009 Jan; 113(3):659-67. PubMed ID: 18931345
[TBL] [Abstract][Full Text] [Related]
11. The pivotal role of uridine-cytidine kinases in pyrimidine metabolism and activation of cytotoxic nucleoside analogues in neuroblastoma.
van Kuilenburg AB; Meinsma R
Biochim Biophys Acta; 2016 Sep; 1862(9):1504-12. PubMed ID: 27239701
[TBL] [Abstract][Full Text] [Related]
12. Purification, activity, and expression levels of two uridine-cytidine kinase isoforms in neuroblastoma cell lines.
Meinsma R; van Kuilenburg AB
Nucleosides Nucleotides Nucleic Acids; 2016 Dec; 35(10-12):613-618. PubMed ID: 27906629
[TBL] [Abstract][Full Text] [Related]
13. Constitutive activation of the ATM/BRCA1 pathway prevents DNA damage-induced apoptosis in 5-azacytidine-resistant cell lines.
Imanishi S; Umezu T; Ohtsuki K; Kobayashi C; Ohyashiki K; Ohyashiki JH
Biochem Pharmacol; 2014 Jun; 89(3):361-9. PubMed ID: 24680865
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of uridine-cytidine kinase by 5-azacytidine 5'-triphosphate.
Lee TT; Momparier RL
Med Pediatr Oncol; 1976; 2(3):265-70. PubMed ID: 62274
[TBL] [Abstract][Full Text] [Related]
15. Combination of azacytidine and curcumin is a potential alternative in decitabine-resistant colorectal cancer cells with attenuated deoxycytidine kinase.
Hosokawa M; Seiki R; Iwakawa S; Ogawara KI
Biochem Biophys Res Commun; 2021 Nov; 578():157-162. PubMed ID: 34571370
[TBL] [Abstract][Full Text] [Related]
16. A crucial role of uridine/cytidine kinase 2 in antitumor activity of 3'-ethynyl nucleosides.
Murata D; Endo Y; Obata T; Sakamoto K; Syouji Y; Kadohira M; Matsuda A; Sasaki T
Drug Metab Dispos; 2004 Oct; 32(10):1178-82. PubMed ID: 15280220
[TBL] [Abstract][Full Text] [Related]
17. Profiles of pyrimidine biosynthesis, salvage and degradation in disks of potato (Solanum tuberosum L.) tubers.
Katahira R; Ashihara H
Planta; 2002 Sep; 215(5):821-8. PubMed ID: 12244448
[TBL] [Abstract][Full Text] [Related]
18. Acute myeloid leukemia cells MOLM-13 and SKM-1 established for resistance by azacytidine are crossresistant to P-glycoprotein substrates.
Messingerova L; Imrichova D; Kavcova H; Turakova K; Breier A; Sulova Z
Toxicol In Vitro; 2015 Oct; 29(7):1405-15. PubMed ID: 26009263
[TBL] [Abstract][Full Text] [Related]
19. TFT and 6TG resistance of mouse lymphoma cells to analogs of azacytidine.
McGregor DB; Brown AG; Cattanach P; Shepherd W; Riach C; Daston DS; Caspary WJ
Carcinogenesis; 1989 Nov; 10(11):2003-8. PubMed ID: 2478309
[TBL] [Abstract][Full Text] [Related]
20. Solute Carrier Family 29A1 Mediates In Vitro Resistance to Azacitidine in Acute Myeloid Leukemia Cell Lines.
Kutyna MM; Loone S; Saunders VA; White DL; Kok CH; Hiwase DK
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
